Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
For farmers and ranchers, the biggest near-term pieces are in the safety net.
Strong cattle prices continue as USDA monitors the impact of New World screwworm along the southern border.
Higher transportation costs through the Gulf are adding another cost consideration for grain exporters and producers.
USDA says total food spending has continued to climb as consumers spend more dining away from home.
The funding will support construction and renovation projects aimed at strengthening agricultural research nationwide.
Stratovation Group says biologicals are becoming more integrated into crop production decisions.
